Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY study

Niels M.R. van der Sangen, I. Tarik Küçük, Shabiga Sivanesan, Yolande Appelman, Jurriën M. ten Berg, Ashley Verburg, Jaouad Azzahhafi, E. Karin Arkenbout, Wouter J. Kikkert, Ron Pisters, J. Wouter Jukema, Fatih Arslan, Arnoud van ‘t Hof, Mustafa Ilhan, Loes P. Hoebers, René J. van der Schaaf, Peter Damman, Pier Woudstra, Tim P. van de Hoef, Matthijs BaxRutger L. Anthonio, Jawed Polad, Tom Adriaenssens, Willem Dewilde, Carlo Zivelonghi, Peep Laanmets, Risko Majas, Marcel G.W. Dijkgraaf, Bimmer E.P.M. Claessen, José P.S. Henriques*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY study'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience